Annovis Gross Profit from 2010 to 2024

ANVS Stock

USD 6.54 0.02 0.30%

Annovis Bio Gross Profit yearly trend continues to be comparatively stable with very little volatility. Gross Profit is likely to outpace its year average in 2024. Gross Profit is the profit Annovis Bio makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals

Gross Profit

First Reported

2010-12-31

Previous Quarter

156.4 K

Current Value

263.2 K

Quarterly Volatility

65.7 K

Credit Downgrade

Yuan Drop

Covid

Check Annovis Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Annovis Bio's main balance sheet or income statement drivers, such as Interest Expense of 199.6 K, Selling General Administrative of 6.6 B or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Annovis financial statements analysis is a perfect complement when working with Annovis Bio Valuation or Volatility modules.

Check out the analysis of Annovis Bio Correlation against competitors.

For more information on how to buy Annovis Stock please use our How to Invest in Annovis Bio guide.

Latest Annovis Bio's Gross Profit Growth Pattern

Below is the plot of the Gross Profit of Annovis Bio over the last few years. Gross profit is a required income statement account that reflects total revenue of Annovis Bio minus its cost of goods sold. It is profit before Annovis Bio operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Annovis Bio's Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Annovis Bio's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 0

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Gross Profit

Timeline

Annovis Gross Profit Regression Statistics

	Arithmetic Mean	156,057
	Geometric Mean	0.00
	Coefficient Of Variation	42.13
	Mean Deviation	40,237
	Median	173,723
	Standard Deviation	65,739
	Sample Variance	4.3B
	Range	263.2K
	R-Value	0.66
	Mean Square Error	2.6B
	R-Squared	0.43
	Significance	0.01
	Slope	9,672
	Total Sum of Squares	60.5B

Annovis Gross Profit History

	2024	263.2 K
	2023	156.4 K
	2012	173.7 K
	2011	null
	2010	10.3 K

Other Fundumenentals of Annovis Bio

Gross Profit Margin

Annovis Bio Gross Profit component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Intangible Assets	Common Stock	Property Plant Equipment	Good Will	Net Debt	Capital Surpluse	Net Invested Capital	Net Working Capital	Capital Stock	Long Term Debt	Long Term Debt Total	Deferred Long Term Liab
Total Assets		0.92	0.75	-0.36	0.52	0.21	-0.04	0.99	0.12	-0.15	0.23	-0.15	-0.92	0.7	0.89	0.92	0.67	-0.1	-0.1	-0.1
Total Stockholder Equity	0.92		0.5	-0.03	0.41	0.21	-0.42	0.91	0.24	0.0	0.21	0.02	-0.9	0.43	0.93	0.9	0.49	0.23	0.23	0.23
Net Tangible Assets	0.75	0.5		-0.88	0.34	-0.05	0.45	0.76	-0.24	-0.12	-0.03	-0.21	-0.66	0.98	0.54	0.67	0.9	-0.66	-0.66	-0.66
Retained Earnings	-0.36	-0.03	-0.88		-0.18	0.15	-0.75	-0.37	0.43	0.2	0.15	0.32	0.27	-0.89	-0.12	-0.28	-0.78	0.87	0.87	0.87
Accounts Payable	0.52	0.41	0.34	-0.18		0.82	0.19	0.41	0.69	-0.13	0.85	-0.16	-0.17	0.21	0.16	0.17	0.17	-0.06	-0.06	-0.06
Net Receivables	0.21	0.21	-0.05	0.15	0.82		-0.03	0.09	0.81	-0.2	0.98	-0.22	0.12	-0.19	-0.11	-0.12	-0.19	0.12	0.12	0.12
Total Liab	-0.04	-0.42	0.45	-0.75	0.19	-0.03		-0.04	-0.32	-0.37	0.01	-0.45	0.17	0.5	-0.32	-0.16	0.32	-0.78	-0.78	-0.78
Total Current Assets	0.99	0.91	0.76	-0.37	0.41	0.09	-0.04		0.0	-0.17	0.1	-0.17	-0.96	0.73	0.93	0.96	0.71	-0.09	-0.09	-0.09
Intangible Assets	0.12	0.24	-0.24	0.43	0.69	0.81	-0.32	0.0		0.35	0.87	0.36	0.16	-0.39	-0.1	-0.16	-0.38	0.34	0.34	0.34
Common Stock	-0.15	0.0	-0.12	0.2	-0.13	-0.2	-0.37	-0.17	0.35		-0.11	0.98	0.14	-0.18	-0.12	-0.14	-0.2	0.11	0.11	0.11
Property Plant Equipment	0.23	0.21	-0.03	0.15	0.85	0.98	0.01	0.1	0.87	-0.11		-0.13	0.12	-0.17	-0.1	-0.12	-0.18	0.11	0.11	0.11
Good Will	-0.15	0.02	-0.21	0.32	-0.16	-0.22	-0.45	-0.17	0.36	0.98	-0.13		0.12	-0.26	-0.09	-0.12	-0.29	0.18	0.18	0.18
Net Debt	-0.92	-0.9	-0.66	0.27	-0.17	0.12	0.17	-0.96	0.16	0.14	0.12	0.12		-0.67	-0.98	-1.0	-0.68	-0.01	-0.01	-0.01
Capital Surpluse	0.7	0.43	0.98	-0.89	0.21	-0.19	0.5	0.73	-0.39	-0.18	-0.17	-0.26	-0.67		0.54	0.68	0.92	-0.68	-0.68	-0.68
Net Invested Capital	0.89	0.93	0.54	-0.12	0.16	-0.11	-0.32	0.93	-0.1	-0.12	-0.1	-0.09	-0.98	0.54		0.98	0.6	0.17	0.17	0.17
Net Working Capital	0.92	0.9	0.67	-0.28	0.17	-0.12	-0.16	0.96	-0.16	-0.14	-0.12	-0.12	-1.0	0.68	0.98		0.69	0.01	0.01	0.01
Capital Stock	0.67	0.49	0.9	-0.78	0.17	-0.19	0.32	0.71	-0.38	-0.2	-0.18	-0.29	-0.68	0.92	0.6	0.69		-0.48	-0.48	-0.48
Long Term Debt	-0.1	0.23	-0.66	0.87	-0.06	0.12	-0.78	-0.09	0.34	0.11	0.11	0.18	-0.01	-0.68	0.17	0.01	-0.48		1.0	1.0
Long Term Debt Total	-0.1	0.23	-0.66	0.87	-0.06	0.12	-0.78	-0.09	0.34	0.11	0.11	0.18	-0.01	-0.68	0.17	0.01	-0.48	1.0		1.0
Deferred Long Term Liab	-0.1	0.23	-0.66	0.87	-0.06	0.12	-0.78	-0.09	0.34	0.11	0.11	0.18	-0.01	-0.68	0.17	0.01	-0.48	1.0	1.0

Click cells to compare fundamentals

About Annovis Bio Financial Statements

Annovis Bio shareholders use historical fundamental indicators, such as Gross Profit, to determine how well the company is positioned to perform in the future. Although Annovis Bio investors may analyze each financial statement separately, they are all interrelated. The changes in Annovis Bio's assets and liabilities, for example, are also reflected in the revenues and expenses on on Annovis Bio's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

		Last Reported	Projected for Next Year
	Gross Profit	156.4 K	263.2 K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Annovis Stock Analysis

When running Annovis Bio's price analysis, check to measure Annovis Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annovis Bio is operating at the current time. Most of Annovis Bio's value examination focuses on studying past and present price action to predict the probability of Annovis Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Annovis Bio's price. Additionally, you may evaluate how the addition of Annovis Bio to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC